What it means in practice
Many common medicines have anticholinergic effects, including some used for overactive bladder, depression, allergy and Parkinson's disease. PrescQIPP's bulletin on anticholinergic burden notes that a growing number of systematic reviews link these medicines to cognitive impairment, falls and all-cause mortality in older people, and recommends prescribing them with caution in older people and people with frailty, reviewing them regularly, and stopping or switching to a lower-burden option where there's no absolute need. Several scales score the burden, such as the Anticholinergic Cognitive Burden (ACB) scale; there is no single standard scale. Because the burden builds up across several prescriptions, it's a common focus of structured medication reviews.
Good practice
- Calculate the anticholinergic burden at medication reviews for older people and people with frailty
- Avoid prescribing anticholinergics alongside acetylcholinesterase inhibitors
- Stop or switch to a lower-burden option where there's no clear need
- Review after a fall or a new episode of confusion
Questions
Which scale should I use to measure anticholinergic burden?
There's no single standard scale. The Anticholinergic Cognitive Burden (ACB) scale is widely used; use the one your local guidance recommends and be consistent.
Sources
Checked against these sources on 19 November 2026.